Hevia Vital, Gómez Victoria, Álvarez Sara, Díez-Nicolás Víctor, Fernández Ana, Burgos Francisco Javier
Urology Department, Hospital Universitario Ramón y Cajal, Alcalá University, Madrid, Spain,
Curr Urol Rep. 2015 Jan;16(1):470. doi: 10.1007/s11934-014-0470-x.
Kidney transplant is the best alternative of treatment for patients with end-stage renal disease (ESRD). At present, a significant part of patients admitted to waiting list are older and have previous transplants or severe vascular atheromatosis. In these cases, orthotopic kidney transplant (OKT) could be an option. The aim of the study is to present our results with this technique in terms of surgical steps, complications, and outcomes. Between January 1977 and August 2014, 1549 kidney transplants were performed in our transplant unit. Nine of them were OKT and were performed according to principles described by Gil-Vernet. All data were reviewed retrospectively. Nine OKTs were performed in seven males and two females, with a mean age of 49.3 years (range 24-67). Donor mean age was 40.5 (18.5-62.5) and the follow-up mean time was of 91.8 months (8-226). Seven cases were first transplants and two were third transplants, all of them from deceased donors. Indication for the OKT was an unsuitable iliac region in six (66.6%) and abnormalities in the low urinary tract or urinary diversions in three (33.3%). Delayed graft function (DGF) was present in 22.2% (2/9). Three patients (33.3%) developed early surgical complications: one bleeding (Clavien IIIb), one arterial thrombosis (IIIb), and one pancreatic leak (IIIb). Two patients (25%) had late complications: one ureteral stricture (IIIb) and one reflux nephropathy (IIIa). Mean serum creatinine after OKT was 1.7, 1.5, and 1.8 mg/dl at 1 month, 1 year, and 5 years, respectively. Mean graft survival was 80.7 months (range 0-226). At present, three patients are alive with functioning graft, three patients died with functioning graft, two patients returned to dialysis many years after the transplant, and one lost the graft due to an arterial thrombosis in the early postoperative course. OKT is a valid option for patients with unsuitable iliac regions such as those with third transplants, severe atheromatosis, or vena cava thrombosis. It is also an option for those patients with urinary diversions. Functional results are good, although it is a technique not exempted from complications. Two thirds of the patients have a long-term survival of the graft, and a third of the patients die with functioning graft.
肾移植是终末期肾病(ESRD)患者最佳的治疗选择。目前,进入等待名单的患者中有很大一部分年龄较大,曾接受过移植手术或患有严重的血管动脉粥样硬化。在这些情况下,原位肾移植(OKT)可能是一种选择。本研究的目的是从手术步骤、并发症和治疗结果方面介绍我们采用该技术的结果。1977年1月至2014年8月期间,我们的移植单位共进行了1549例肾移植手术。其中9例为原位肾移植,均按照吉尔 - 韦尔内描述的原则进行。所有数据均进行回顾性分析。9例原位肾移植手术中,7例为男性,2例为女性,平均年龄49.3岁(范围24 - 67岁)。供体平均年龄为40.5岁(18.5 - 62.5岁),平均随访时间为91.8个月(8 - 226个月)。7例为首次移植,2例为第三次移植,所有供体均为脑死亡供体。原位肾移植的适应证为6例(66.6%)髂区不适合,3例(33.3%)下尿路异常或尿路改道。22.2%(2/9)的患者出现移植肾功能延迟恢复(DGF)。3例患者(33.3%)发生早期手术并发症:1例出血(Clavien IIIb级),1例动脉血栓形成(IIIb级),1例胰瘘(IIIb级)。2例患者(25%)出现晚期并发症:1例输尿管狭窄(IIIb级),1例反流性肾病(IIIa级)。原位肾移植术后1个月、1年和5年的平均血清肌酐分别为1.7、1.5和1.8mg/dl。平均移植肾存活时间为80.7个月(范围0 - 226个月)。目前,3例患者移植肾仍在发挥功能且存活,3例患者移植肾仍在发挥功能但已死亡,2例患者在移植多年后恢复透析,1例患者在术后早期因动脉血栓形成而失去移植肾。对于髂区不适合的患者,如接受第三次移植、患有严重动脉粥样硬化或腔静脉血栓形成的患者,原位肾移植是一种有效的选择。对于那些尿路改道的患者也是一种选择。尽管该技术难免会出现并发症,但功能结果良好。三分之二的患者移植肾长期存活,三分之一的患者移植肾仍在发挥功能但已死亡。